
<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>TGME49_268850 - Expression Summary</title>
  <style>
    body { font-family: Arial, sans-serif; line-height: 1.6; margin: 20px; }
    h1, h2, h3 { color: #333; }
    table { width: 100%; border-collapse: collapse; margin-bottom: 20px; }
    th, td { border: 1px solid #ddd; padding: 8px; text-align: left; }
    th { background-color: #f4f4f4; }
    img { max-width: 100px; }
    .human-readable { max-width: 50em; }
  </style>
</head>
<body>
  <h1><a href="https://toxodb.org/toxo/app/record/gene/TGME49_268850">TGME49_268850</a> - Dramatically elevated expression during sexual development with sustained high levels in tachyzoites</h1>
  <div class="human-readable">This gene exhibits <strong>dramatically elevated expression during sexual development</strong> in <i>Toxoplasma gondii</i>, with 20-25 fold increases in enteroepithelial stages (EES1-5) compared to asexual stages, reaching 2,500-2,800 TPM in the feline intestinal environment. Expression remains <strong>consistently high in tachyzoites</strong> (600-1,100 TPM) across multiple strains and time points, while being <strong>substantially lower in bradyzoites and oocyst stages</strong>. The gene shows <strong>cell cycle-dependent regulation</strong> with periodic expression patterns and varies by <strong>host cell type and infection context</strong>. <ul><li>Peak expression occurs during sexual reproduction in feline hosts</li><li>Maintains high levels during rapid tachyzoite replication</li><li>Reduced during chronic infection and cyst formation</li></ul> This expression pattern suggests critical roles in both sexual reproduction and acute infection processes.</div>
  
    <section>
      <h2>Peak expression during sexual development with stage-specific regulation across parasite life cycle</h2>
      <p class="human-readable">Expression reaches maximum levels (2,500-2,800 TPM) in enteroepithelial stages during sexual development, remains high in tachyzoites and merozoites, but dramatically decreases in oocysts and bradyzoites, indicating critical roles in sexual reproduction and acute infection phases.</p>
      <table>
        <thead>
          <tr>
            <th>Preview</th>
            <th>Name</th>
            <th>Summary</th>
            <th>Biological Importance</th>
            <th>Attribution</th>
            <th>Assay Type</th>
          </tr>
        </thead>
        <tbody>
    
<tr>
<td><img id="ExpressionGraphs__DS_e7467c0306" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_e7467c0306&default=1"/></td>
<td>Feline enterocyte, tachyzoite, bradyzoite stage transcriptome</td>
<td class="human-readable">This gene shows dramatically elevated expression (20-25 fold increase) across all enteroepithelial stages (EES1-EES5) compared to tachyzoites and tissue cysts, indicating strong upregulation during sexual development in the feline intestinal environment.</td>
<td>5A</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/30728393">Hehl, Ramakrishnan et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_173528b522" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_173528b522&default=1"/></td>
<td>Full life-cycle transcriptome of T. gondii</td>
<td class="human-readable">This gene shows markedly elevated expression in enteroepithelial stages (EES1-5) with TPM values of ~2,500-2,800, moderately high expression in tachyzoites (~1,100 TPM), and dramatically lower expression in all oocyst stages (unsporulated, sporulating, and sporulated) with TPM values below 36.</td>
<td>5A</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/30728393">Ramakrishnan et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_2750122e82" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_2750122e82&default=1"/></td>
<td>Oocyst, tachyzoite, and bradyzoite developmental expression profiles (M4)</td>
<td class="human-readable">This gene shows highest expression in <i>Toxoplasma gondii</i> tachyzoites (2 days in vitro), with moderate expression in mature bradyzoites and sporulated oocysts, and lowest expression in unsporulated oocysts and in vivo bradyzoites.</td>
<td>4B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/22347997">Fritz and Buchholz et al.</a></td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_45b4123102" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_45b4123102&default=1"/></td>
<td>Merozoite Gene Expression</td>
<td class="human-readable">This gene shows strong upregulation in <i>Toxoplasma gondii</i> merozoites compared to tachyzoites, with expression levels consistently elevated across all three cat-derived merozoite samples (RMA values ~13.5-13.7) relative to the tachyzoite control (RMA value 11.1).</td>
<td>4B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/24885521">Behnke et al.</a></td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_59fb8debdb" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_59fb8debdb&default=1"/></td>
<td>T. gondii during infection in IEC18 cells (Dual RNA-Seq)</td>
<td class="human-readable">This gene shows dramatically higher expression in <i>Toxoplasma gondii</i> tachyzoites (748-813 TPM, 98th percentile) compared to sporozoites (67 TPM, 91st percentile) and is completely absent in frozen sporozoite controls.</td>
<td>4B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/28362800">Guiton et al. 2017</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_749cb10dcf" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_749cb10dcf&default=1"/></td>
<td>Stage-specific RNA-sequencing in Toxoplasma gondii</td>
<td class="human-readable">This gene is significantly downregulated in <i>Toxoplasma gondii</i> bradyzoites compared to tachyzoites, showing approximately 2-fold lower expression (307 vs 594 TPM) during the chronic stage differentiation.</td>
<td>4B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/31955846">Waldman et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_75742b9a0a" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_75742b9a0a&default=1"/></td>
<td>Tachyzoite and merozoite transcriptomes</td>
<td class="human-readable">This gene is highly expressed in both <i>T. gondii</i> life cycle stages but shows significantly higher expression in merozoites (1337 TPM) compared to tachyzoites (899 TPM), representing a 1.5-fold upregulation in the merozoite stage.</td>
<td>3B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/25757795">Hehl et al.</a></td>
<td>RNA-Seq</td>
</tr>
        </tbody>
      </table>
    </section>
  
    <section>
      <h2>Sustained high expression throughout tachyzoite development with temporal variation</h2>
      <p class="human-readable">Gene maintains consistently high expression (600-1,100 TPM, >96th percentile) across multiple tachyzoite time courses and strains, with some temporal peaks and strain-specific variation, but overall constitutive high-level transcription during the acute infection stage.</p>
      <table>
        <thead>
          <tr>
            <th>Preview</th>
            <th>Name</th>
            <th>Summary</th>
            <th>Biological Importance</th>
            <th>Attribution</th>
            <th>Assay Type</th>
          </tr>
        </thead>
        <tbody>
    
<tr>
<td><img id="ExpressionGraphs__DS_78959dea55" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_78959dea55&default=1"/></td>
<td>Tachyzoite Transcriptome Time Series (VEG)</td>
<td class="human-readable">This gene shows very high expression in the sense orientation (630-1118 TPM, 97th-98th percentile) with peak expression at 16 hours post-infection, while antisense expression remains consistently low (3-12 TPM, 84th-94th percentile) throughout the <i>T. gondii</i> tachyzoite time course.</td>
<td>4A</td>
<td>Gregory</td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_d5645bc639" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_d5645bc639&default=1"/></td>
<td>Tachyzoite Transcriptome Time Series (ME49)</td>
<td class="human-readable">This gene shows consistently high expression throughout the <i>T. gondii</i> tachyzoite infection time course with TPM values ranging from 532-1077, peaking at 36 hours post-infection, and exhibits negligible antisense transcription.</td>
<td>4B</td>
<td>Gregory</td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_6529b4f68d" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_6529b4f68d&default=1"/></td>
<td>Tachyzoite Transcriptome Time Series (RH)</td>
<td class="human-readable">This gene shows high expression in <i>T. gondii</i> tachyzoites with peak levels at 22 hours post-infection (1723.32 TPM, 98.87th percentile), followed by moderate expression at 2 hours (952.56 TPM, 97.95th percentile) and lower expression at 36 hours (609.88 TPM, 96.7th percentile), indicating temporal regulation during the parasite life cycle.</td>
<td>4B</td>
<td>Gregory</td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_ef984802b1" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_ef984802b1&default=1"/></td>
<td>Tachyzoite Transcriptome Time Series (GT1)</td>
<td class="human-readable">This gene shows consistently high expression throughout the 16-hour time course in <i>T. gondii</i> GT1 tachyzoites with transcript levels ranging from ~750-1,231 TPM and ranking in the 97th-98th percentile among all genes.</td>
<td>4B</td>
<td>Gregory</td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_94e899930e" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_94e899930e&default=1"/></td>
<td>Tachyzoite Transcriptome 3 and 4 days post-infection (VEG NcLIV)</td>
<td class="human-readable">This gene shows consistently very high expression in <i>Toxoplasma gondii</i> tachyzoites with a slight increase from day 3 to day 4 post-infection (960-1044 TPM), ranking in the 98th percentile of all genes.</td>
<td>4B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/22457617">Reid et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_386bac2860" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_386bac2860&default=1"/></td>
<td>T. gondii during spontaneous differentiation in primary rat brain cells.</td>
<td class="human-readable">This gene shows high expression in tachyzoites and early infection stages (days 1-2) that dramatically decreases by day 4 and remains low through day 14, while antisense transcription increases over time during <i>Toxoplasma gondii</i> differentiation in rat brain cells.</td>
<td>4B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/34610266">Mouveaux et al. 2021</a></td>
<td>RNA-Seq</td>
</tr>
        </tbody>
      </table>
    </section>
  
    <section>
      <h2>Host cell type and infection context influence expression levels</h2>
      <p class="human-readable">Expression varies significantly by host cell type (7-11 fold lower in fibroblasts versus other cell types), infection location (higher intracellular versus extracellular), and infection stage (5-fold decrease from acute to chronic brain infection), indicating host-dependent regulation.</p>
      <table>
        <thead>
          <tr>
            <th>Preview</th>
            <th>Name</th>
            <th>Summary</th>
            <th>Biological Importance</th>
            <th>Attribution</th>
            <th>Assay Type</th>
          </tr>
        </thead>
        <tbody>
    
<tr>
<td><img id="ExpressionGraphs__DS_a48cc7c61e" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_a48cc7c61e&default=1"/></td>
<td>Comparative ribosome profiling of intracellular and extracellular parasites</td>
<td class="human-readable">This gene shows substantially higher expression in intracellular versus extracellular <i>Toxoplasma gondii</i> parasites, with approximately 1.8-fold higher RNA levels and 4.3-fold higher ribosome-protected fragment levels inside host cells.</td>
<td>4B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/29228904">Hassan et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_930295d0b5" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_930295d0b5&default=1"/></td>
<td>T gondii Transcriptome during infection in 4 mouse cell types</td>
<td class="human-readable">This gene shows high expression across most cell types during <i>T. gondii</i> infection, with substantially lower expression in fibroblasts (36.29 TPM) compared to neurons, astrocytes, and skeletal muscle cells (271-388 TPM).</td>
<td>4B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/28775382">Swierzy et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_b0427cd47b" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_b0427cd47b&default=1"/></td>
<td>Transcriptome during acute or chronic infection in mouse brain</td>
<td class="human-readable">This gene shows substantial downregulation in <i>Toxoplasma gondii</i> during chronic infection (28 days) compared to acute infection (10 days), with expression decreasing approximately 5-fold from 429.32 to 86.7 TPM.</td>
<td>4B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/25240600">Pittman et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_4362334059" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_4362334059&default=1"/></td>
<td>Parasite transcriptome during infection in mouse brain.</td>
<td class="human-readable">This <i>Toxoplasma gondii</i> gene shows markedly higher expression in Type III strain-infected neurons (279.52 TPM, 95.76th percentile) compared to Type II strain-infected neurons (61.1 TPM, 84.24th percentile), with minimal expression in bystander neurons from both strains.</td>
<td>4B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/32878927">Merritt et al.</a></td>
<td>RNA-Seq</td>
</tr>
        </tbody>
      </table>
    </section>
  
    <section>
      <h2>Cell cycle-regulated expression with periodic peaks during parasite division</h2>
      <p class="human-readable">Gene exhibits clear biphasic expression pattern with ~6-hour periodicity, peaking at hours 0-1 and 7-8 post-thymidine synchronization, indicating tight cell cycle regulation during tachyzoite replication.</p>
      <table>
        <thead>
          <tr>
            <th>Preview</th>
            <th>Name</th>
            <th>Summary</th>
            <th>Biological Importance</th>
            <th>Attribution</th>
            <th>Assay Type</th>
          </tr>
        </thead>
        <tbody>
    
<tr>
<td><img id="ExpressionGraphs__DS_c1a3dbb014" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_c1a3dbb014&default=1"/></td>
<td>Cell Cycle Expression Profiles (RH)</td>
<td class="human-readable">This gene exhibits strong periodic expression during the <i>Toxoplasma gondii</i> cell cycle, with peak expression at hours 0-1 and 7-8 post-thymidine synchronization, dropping to minimum levels around hours 3-4, indicating cell cycle-regulated transcription.</td>
<td>4B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/20865045">Behnke et al.</a></td>
<td>array</td>
</tr>
        </tbody>
      </table>
    </section>
  
    <section>
      <h2>Moderate expression in bradyzoites with temporal changes during chronic infection</h2>
      <p class="human-readable">Gene shows intermediate expression levels in bradyzoites (337 TPM, 94th percentile) that vary over time during chronic infection, with notable differences between in vitro and in vivo conditions.</p>
      <table>
        <thead>
          <tr>
            <th>Preview</th>
            <th>Name</th>
            <th>Summary</th>
            <th>Biological Importance</th>
            <th>Attribution</th>
            <th>Assay Type</th>
          </tr>
        </thead>
        <tbody>
    
<tr>
<td><img id="ExpressionGraphs__DS_408f2c4cda" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_408f2c4cda&default=1"/></td>
<td>Bradyzoite in vitro Transcriptome (ME49)</td>
<td class="human-readable">This gene shows high expression in <i>Toxoplasma gondii</i> bradyzoites with 337.37 TPM on the sense strand, ranking in the 94th percentile compared to all genes in this experiment.</td>
<td>4B</td>
<td>Sibley/Gregory</td>
<td>RNA-Seq</td>
</tr>
        </tbody>
      </table>
    </section>
  
    <section>
      <h2>Increased expression during oocyst maturation over extended time periods</h2>
      <p class="human-readable">Expression increases dramatically (>70-fold) from 0.88 to 63.04 TPM during 10-day oocyst sporulation, indicating important roles in oocyst development and maturation processes.</p>
      <table>
        <thead>
          <tr>
            <th>Preview</th>
            <th>Name</th>
            <th>Summary</th>
            <th>Biological Importance</th>
            <th>Attribution</th>
            <th>Assay Type</th>
          </tr>
        </thead>
        <tbody>
    
<tr>
<td><img id="ExpressionGraphs__DS_72dce52949" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_72dce52949&default=1"/></td>
<td>Oocyst Time Series (M4)</td>
<td class="human-readable">This gene shows strong upregulation during <i>Toxoplasma gondii</i> oocyst maturation, with expression levels increasing dramatically from 0.88 TPM at day 0 to 63.04 TPM at day 10 post-sporulation.</td>
<td>4B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/22347997">Fritz/Boothroyd/Gregory</a></td>
<td>RNA-Seq</td>
</tr>
        </tbody>
      </table>
    </section>
  
    <section>
      <h2>Other</h2>
      <p class="human-readable">These experiments were not grouped by the AI.</p>
      <table>
        <thead>
          <tr>
            <th>Preview</th>
            <th>Name</th>
            <th>Summary</th>
            <th>Biological Importance</th>
            <th>Attribution</th>
            <th>Assay Type</th>
          </tr>
        </thead>
        <tbody>
    
<tr>
<td><img id="ExpressionGraphs__DS_73d06a9e7b" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_73d06a9e7b&default=1"/></td>
<td>Expression profiling of 3 archetypal lineages</td>
<td class="human-readable">This gene shows moderate differential expression across <i>T. gondii</i> lineages, with highest expression in Type I strains (RH: 9.17, GT1: 8.31) compared to Type II (Pru: 7.14, ME49: 8.02) and Type III (CTG: 8.22, VEG: 7.69) strains.</td>
<td>3B</td>
<td>Davis and Roos, unpublished</td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_d459caa7da" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_d459caa7da&default=1"/></td>
<td>Tachyzoite transcriptome during invasion (RH)</td>
<td class="human-readable">This gene shows high expression across all conditions in <i>Toxoplasma gondii</i> tachyzoites, with a notable transient decrease immediately after invasion (10.31) compared to extracellular parasites (11.29) and 2-hour post-invasion parasites (11.83).</td>
<td>3B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/21166903">Gaji et al.</a></td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_994d646c6a" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_994d646c6a&default=1"/></td>
<td>Bradyzoite Differentiation (Multiple 6-hr time points and Extended time series)</td>
<td class="human-readable">This gene shows consistently high expression throughout <i>Toxoplasma gondii</i> bradyzoite differentiation with RMA values typically ranging from 8-11 (log2 scale) and percentiles consistently above 80%, indicating sustained upregulation without major temporal changes during the transition from tachyzoites to bradyzoites.</td>
<td>3B</td>
<td>Davis and Roos et al.</td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_2daab8c933" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_2daab8c933&default=1"/></td>
<td>Bradyzoite Differentiation Expression Profiles (ME49, GT1, CTGara)</td>
<td class="human-readable">This gene shows consistently high expression across all <i>Toxoplasma gondii</i> strains and conditions, with modest but consistent downregulation during bradyzoite differentiation induced by both Compound 1 and pH 8.2 treatments.</td>
<td>3B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/18433450">Behnke et al.</a></td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_50943f57a2" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_50943f57a2&default=1"/></td>
<td>Bradyzoite Differentiation (3-day time series)(Pru)</td>
<td class="human-readable">This gene shows a steady downregulation during <i>Toxoplasma gondii</i> bradyzoite differentiation, with expression decreasing from 12.49 to 11.61 log2 units over 4 days while maintaining very high percentile rankings (97.98% to 96%).</td>
<td>3B</td>
<td>Buchholz, Fritz and Boothroyd et al.</td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_dac07dbf93" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_dac07dbf93&default=1"/></td>
<td>Bradyzoite in vivo transcriptome (M4)</td>
<td class="human-readable">This gene shows moderate expression in <i>Toxoplasma gondii</i> bradyzoites with higher antisense transcript levels (10.28 TPM, 96.6th percentile) compared to sense transcripts (6.19 TPM, 31.17th percentile).</td>
<td>3B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/22021236">Buchholz et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_485e6e94e3" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_485e6e94e3&default=1"/></td>
<td>Transcriptomes of 29 strains during murine macrophage infection</td>
<td class="human-readable">This gene shows consistently high expression across all 29 <i>Toxoplasma gondii</i> strains during macrophage infection, with transcript levels ranging from ~312 to 1,669 TPM and percentile rankings consistently above the 94th percentile, indicating constitutive high-level expression with modest strain-to-strain variation.</td>
<td>3B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/22847430">Minot et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_95bf119b5c" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_95bf119b5c&default=1"/></td>
<td>RNA-seq of tartrolon E-treated T. gondii RH parasites</td>
<td class="human-readable">This gene shows dose-dependent downregulation in response to tartrolon E treatment in <i>Toxoplasma gondii</i>, with expression decreasing from ~965-999 TPM in controls to ~447-485 TPM at the highest dose (24.2 nM) and intermediate levels (~877-1007 TPM) at the lower dose (6 nM).</td>
<td>3B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/32738587">Bowden et al. 2020</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_4a81d92b98" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_4a81d92b98&default=1"/></td>
<td>RNA-Seq of CPSF4 WT and CPSF4 KD parasites</td>
<td class="human-readable">This gene shows high expression levels (735-1,247 TPM) in the sense direction with a transient increase at 7 hours following CPSF4 knockdown in <i>Toxoplasma gondii</i>, followed by a decline to below baseline levels by 48 hours.</td>
<td>3B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/34263725">Farhat et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_3a839edb9c" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_3a839edb9c&default=1"/></td>
<td>Transcriptome of Wild-Type and gra18 mutant strains of T. gondii</td>
<td class="human-readable">This gene shows consistently high expression across all conditions with modest upregulation in the GRA18 complemented strain compared to wild-type and GRA18 knockout strains, with no substantial effect from LPS treatment.</td>
<td>2B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/30320549">He et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_79e1396920" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_79e1396920&default=1"/></td>
<td>RNA-Seq of MORC WT and MORC KD parasites</td>
<td class="human-readable">This gene shows consistently high expression (>1400 TPM) across all conditions in <i>Toxoplasma gondii</i>, with modest increases upon FR235222 treatment and a notable decrease after 48 hours of IAA treatment in the PRU MORC KD strain.</td>
<td>2B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/32094587">Farhat et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_0d220fc0c6" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_0d220fc0c6&default=1"/></td>
<td>Mouse brain bradyzoite transcriptomes at 28, 90, 120 days post infection</td>
<td class="human-readable">This gene shows moderate expression in <i>Toxoplasma gondii</i> bradyzoites with a notable peak at 90 days post-infection (137.7 TPM) compared to 28 and 120 days (~114-115 TPM), suggesting transient upregulation during the intermediate chronic infection stage.</td>
<td>2C</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/31726967">Garfoot et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_35bb13db5b" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_35bb13db5b&default=1"/></td>
<td>Mutants and wild-type expression profiles during bradyzoite differentiation</td>
<td class="human-readable">This gene shows consistently high expression across all conditions in <i>Toxoplasma gondii</i>, with minimal variation between tachyzoite and bradyzoite stages or among differentiation mutants, suggesting constitutive expression that is largely unaffected by life cycle stage transitions or insertional mutations.</td>
<td>1B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/21209930">Lescault et al.</a></td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_e8c4cf2187" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_e8c4cf2187&default=1"/></td>
<td>Differential Expression Profiling GCN5-A mutant</td>
<td class="human-readable">This gene shows minimal differential expression in response to alkaline stress in <i>Toxoplasma gondii</i>, with only a slight increase under stress conditions in both wild-type and GCN5-A knockout strains.</td>
<td>1B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/21179246">Naguleswaran et al.</a></td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_1bdad09720" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268850&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_1bdad09720&default=1"/></td>
<td>PMRT1 KO, WT and KOCM expression profiles</td>
<td class="human-readable">This gene shows minimal differential expression across wild-type, PRMT1 knockout, and complement strains in <i>Toxoplasma gondii</i>, with only modest upregulation (0.39 log2 units) in the PRMT1 knockout compared to wild-type.</td>
<td>1B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/26838719">El Bissati et al.</a></td>
<td>array</td>
</tr>
        </tbody>
      </table>
    </section>
  
</body>
<footer>
<p>Generated by the <a href="https://github.com/VEuPathDB/expression-shepherd">Expression Shepherd</a> at commit <a href="https://github.com/VEuPathDB/expression-shepherd/commit/afb6b22" target="_blank">afb6b22</a> on Sun Jul 20 2025 02:41:53 GMT+0100 (British Summer Time)</p>
</footer>
</html>
  